Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,905 | 446 | 1,498 | 3,518 | 5,996 |
| Marketable Securities | 459 | 637 | 31 | 21 | 1,202 |
| Receivables | 231 | 2,936 | 3,232 | 3,412 | 3,807 |
| Inventories | 52 | 78 | 77 | 94 | 117 |
| Other current assets | 3,815 | 5,207 | 5,053 | 2,742 | 861 |
| TOTAL | $6,478 | $9,343 | $10,344 | $9,932 | $12,053 |
| Non-Current Assets | |||||
| PPE Net | 169 | 191 | 228 | 109 | 130 |
| Investments And Advances | 0 | 0 | 0 | 2 | 2 |
| Intangibles | 4,513 | 4,619 | 4,725 | 4,830 | 4,934 |
| TOTAL | $4,683 | $4,810 | $4,953 | $4,942 | $5,066 |
| Total Assets | $11,161 | $14,153 | $15,297 | $14,873 | $17,119 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,773 | 2,405 | 2,109 | 1,245 | 771 |
| Accounts payable and accrued liabilities | 1,982 | 2,609 | 1,871 | 1,321 | 3,255 |
| Accrued Expenses | 2,200 | 1,478 | 1,321 | 1,036 | 1,107 |
| Other current liabilities | N/A | 2 | 7,792 | 5,707 | 492 |
| TOTAL | $6,058 | $6,646 | $13,250 | $10,344 | $6,679 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | 0 | 0 | 1,000 | 1,000 |
| Other Non-Current Liabilities | 1,822 | 1,145 | 1,717 | 1,203 | 1,040 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $6,058 | $6,646 | $13,250 | $10,344 | $6,679 |
| Shareholders' Equity | |||||
| Common Shares | 169,703 | 169,028 | 159,962 | 153,036 | 150,470 |
| Retained earnings | -198,286 | -195,260 | -189,941 | -180,688 | -172,111 |
| Other shareholders' equity | 102 | 1,305 | 1,160 | 1,426 | 2,049 |
| TOTAL | $6,924 | $8,652 | $3,764 | $5,733 | $11,481 |
| Total Liabilities And Equity | $12,983 | $15,299 | $17,014 | $16,077 | $18,160 |